
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
Author(s) -
Eleftherios Pelechas,
Vassiliki Drossou,
Paraskevi V. Voulgari,
Alexandros A. Drosos
Publication year - 2022
Publication title -
mediterranean journal of rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2529-198X
DOI - 10.31138/mjr.33.1.68
Subject(s) - rheumatoid arthritis , medicine , immunology , tumor necrosis factor alpha , immune dysregulation , immune system , disease , chemokine , covid-19 , arthritis , rheumatology , autoimmune disease , rheumatoid factor , infectious disease (medical specialty)